Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus).
Naturally obese female Syrian hamsters were injected daily with prolactin at 0 or 12 h after cortisol injections for 10 days while held in constant light. Controls were similarly injected with saline. Animals were then held on short daylengths (10 h light:14 h darkness) for 10 weeks. They were allowed free access to food and water from birth to time of death. Ten weeks after treatment, retroperitoneal fat stores, plasma concentrations of insulin and glucose, and hypoglycaemic responsiveness to exogenous insulin were determined. The control groups as well as the 12-h hormone treatment group were obese, hyperinsulinaemic and insulin resistant. However, the 0-h treatment dramatically reduced retroperitoneal fat stores (41-55%), plasma insulin concentration (60-70%) and the insulin to glucose ratio (63-68%) compared with controls. Values for these parameters in the 0-h treatment groups were similar to those of their lean litter-mates. Furthermore, the 0-h group but not the 12-h group was more sensitive than control animals to the hypoglycaemic effects of exogenous insulin at doses 0.2 and 2.0 U/kg body weight. These results demonstrate that timed daily injections of cortisol and prolactin in specific temporal relationships can produce marked reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster that persist long after the termination of treatment. This study also suggests an important role for the interactions of circadian neuroendocrine systems in the regulation of these metabolic states.
Cincotta
A H
AH
Department of Zoology and Physiology, Louisiana State University, Baton Rouge 70803.
Wilson
J M
JM
deSouza
C J
CJ
Meier
A H
AH
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002940:Circadian Rhythm; D006224:Cricetinae; D005260:Female; D006854:Hydrocortisone / Q000008:administration & dosage*; D006946:Hyperinsulinism / Q000097:blood / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000187:drug effects*; D008647:Mesocricetus; D009765:Obesity / Q000097:blood / Q000188:drug therapy*; D011388:Prolactin / Q000008:administration & dosage*
D001786:Blood Glucose; D007328:Insulin; D011388:Prolactin; D006854:Hydrocortisone